Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Jiang, Chengyan
Symphony2, NCT06353347: Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes Inadequately Controlled With Metformin	Active, not recruiting	3	551	RoW	HTD1801, berberine ursodeoxycholate, Placebo	HighTide Biopharma Pty Ltd	Type 2 Diabetes Mellitus	03/25	12/25
NCT05963022: A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes (SURPASS-CN-MONO)	Completed	3	168	RoW	Tirzepatide, LY3298176, Placebo	Eli Lilly and Company	Type 2 Diabetes	10/24	10/24
Fu, Xiaohong
SHINY, NCT06157502: Shuxuening Injection in the Treatment With Intravenous Thrombolysis in Patients With Ischemic Stroke	Recruiting	3	1380	RoW	Shuxuening Injection, Placebo	Beijing Tiantan Hospital	Ischemic Stroke, Acute	06/25	12/26